Mercator Medical S.A. (WSE:MRC)
Poland · Delayed Price · Currency is PLN 55.10
-0.30 (-0.54%)
Aug 14, 2026, 5:00 PM CET
Mercator Medical Cash Flow Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 12.3 | 28.59 | 44.63 | -19.68 | -189.62 | 446.87 |
Depreciation & Amortization | 25.41 | 23.99 | 18.79 | 19.66 | 24.01 | 18.38 |
Other Amortization | 4.72 | 4.79 | 4.52 | 2.46 | 1.66 | 0.93 |
Loss (Gain) From Sale of Assets | -3.3 | -3.24 | -0.33 | 0.89 | 6.07 | 0.38 |
Asset Writedown & Restructuring Costs | -5.17 | -5.03 | -55.57 | 14.2 | 127.52 | - |
Loss (Gain) From Sale of Investments | 1.02 | 1.05 | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - | 0.02 |
Other Operating Activities | -12.53 | -33.96 | -2.87 | -93.49 | 9.38 | -122.61 |
Change in Accounts Receivable | -6.97 | 14.13 | -24.65 | -12.22 | 74.08 | 191.38 |
Change in Inventory | 51.04 | 21.84 | -65.09 | 52.91 | 29.74 | -23.4 |
Change in Other Net Operating Assets | 3.92 | -14.67 | 14.55 | 35.18 | -42.04 | -8.94 |
Operating Cash Flow | 70.44 | 37.49 | -66.02 | -0.09 | 40.79 | 503 |
Operating Cash Flow Growth | - | - | - | - | -91.89% | -29.40% |
Capital Expenditures | -55.74 | -50.94 | -18.72 | -39.07 | -109.65 | -176.75 |
Sale of Property, Plant & Equipment | 5.65 | 5.54 | 0.66 | 0.62 | 0.35 | 0.16 |
Investment in Securities | 36.36 | 53.23 | 6.31 | 63.82 | -4.11 | -53.84 |
Other Investing Activities | 22.53 | 23.25 | 4.68 | 8.22 | 9.48 | 0.39 |
Investing Cash Flow | -27.51 | -5.47 | -12.88 | 33.59 | -146.74 | -230.05 |
Short-Term Debt Issued | - | 0.02 | - | - | - | - |
Long-Term Debt Issued | - | - | - | - | 0.21 | - |
Total Debt Issued | 0 | 0.02 | - | - | 0.21 | - |
Short-Term Debt Repaid | - | - | - | - | - | -0.72 |
Long-Term Debt Repaid | - | -1.75 | -0.9 | -0.74 | -1.58 | -1.74 |
Total Debt Repaid | -2.04 | -1.75 | -0.9 | -0.74 | -1.58 | -2.46 |
Net Debt Issued (Repaid) | -2.04 | -1.73 | -0.9 | -0.74 | -1.37 | -2.46 |
Issuance of Common Stock | - | - | - | - | - | 0.75 |
Repurchase of Common Stock | -12.45 | -12.45 | -14.95 | -16.27 | - | -332.08 |
Common Dividends Paid | - | - | - | -23.87 | - | - |
Other Financing Activities | -0.5 | -0.44 | -0.23 | -0.19 | -0.02 | -0.12 |
Financing Cash Flow | -14.99 | -14.62 | -16.08 | -41.07 | -1.39 | -333.91 |
Foreign Exchange Rate Adjustments | 0 | 0.28 | 2.02 | 0.2 | -8.93 | 0.72 |
Net Cash Flow | 27.94 | 17.68 | -92.96 | -7.37 | -116.26 | -60.23 |
Free Cash Flow | 14.7 | -13.45 | -84.75 | -39.15 | -68.86 | 326.25 |
Free Cash Flow Growth | - | - | - | - | - | -53.19% |
Free Cash Flow Margin | 2.57% | -2.34% | -15.62% | -8.34% | -12.69% | 18.87% |
Free Cash Flow Per Share | 1.60 | -1.46 | -9.03 | -4.08 | -7.05 | 32.23 |
Levered Free Cash Flow | 88.97 | 44.86 | -110.05 | -27.59 | -100.51 | 195.43 |
Unlevered Free Cash Flow | 89.3 | 45.16 | -109.84 | -27.07 | -100.3 | 195.5 |
Cash Interest Paid | 0.5 | 0.44 | 0.23 | 0.19 | 0.02 | 0.12 |
Cash Income Tax Paid | 0.76 | 0.79 | 3.59 | 0.52 | 29.93 | 119.99 |
Change in Working Capital | 47.99 | 21.3 | -75.19 | 75.88 | 61.77 | 159.04 |